1 |
CSF2
💬
| [16] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Shigellosis, Amoebiasis, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Coronavirus disease - COVID-19, Transcriptional misregulation in cancer, Acute myeloid leukemia, Rheumatoid arthritis | Otilimab
Otilimab
💬
|
Otilimab
| [1] 46 46 💬
|
2 |
CSF2RA
💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | Molgramostim
Molgramostim
💬
|
Molgramostim
| [3] 97 97, 229, 299 💬
|
3 |
CSF2RA
💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | Regramostim
Regramostim
💬
|
Regramostim
| [1] 229 229 💬
|
4 |
CSF2RA
💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | Sargramostim
Sargramostim
💬
|
Sargramostim
| [7] 6 6, 28, 60, 62, 96, 229, 285 💬
|
5 |
CSF2RA
💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | Mavrilimumab
Mavrilimumab
💬
|
Mavrilimumab
| [2] 41 41, 46 💬
|